THE APEX TIMES
Toronto placed Max Scherzer on the 10-day injured list with back spasms, adding another physical setback for a veteran ace whose season already included time on the injured list for forearm and ankle issues.
Toronto has turned to the injured list again as the Blue Jays placed Max Scherzer on the 10-day IL with back spasms. The move was reported by AP on Wednesday and effectively pauses the work of one of the team’s most experienced starting pitchers, whose presence has been part of the rotation’s stability in recent weeks.
Scherzer, who will turn 42 next month, has already spent significant time unavailable this season. Earlier on, he was placed on the injured list for right forearm tendinitis and later for left ankle inflammation, totaling more than six weeks on the IL across those issues. His latest setback is different in location, but it arrives with the same implication for Toronto’s plans: the team must continue adjusting its pitching workload around uncertainty.
Back spasms are often treated with rest and careful monitoring, and the 10-day window gives the Blue Jays a short horizon in which to evaluate whether Scherzer can return without risking a recurrence. Even when a player’s condition improves, teams typically take a cautious approach with the lower back because it can affect mechanics, pitch delivery, and overall command, especially for high-velocity starters.
For Toronto, the practical challenge is rotation depth. With Scherzer on the IL, the Blue Jays must rely on other starters and bullpen options to cover his next scheduled absence. That can increase innings strain for the remaining pitchers if the rest of the rotation remains healthy, or it can accelerate bullpen usage if additional performance or fatigue issues emerge.
The timing matters as well. Midseason stretches tend to be when teams refine their playoff positioning, and a recurring IL cycle for a top-of-rotation arm can force difficult sequencing decisions, including whether to stretch others farther between starts or reshuffle the order of upcoming matchups. The Blue Jays will need to balance immediate results with a longer view toward keeping their rotation options usable.
Beyond the day-to-day adjustment, Scherzer’s situation also highlights the reality for older pitchers in an MLB workload environment. The combination of past forearm and ankle inflammation with this new back issue raises the stakes of monitoring overall recovery, not just the symptom that appears on the injury report. Toronto will likely watch closely for any signs that the spasms are lingering or tied to a broader physical problem, rather than a short-term episode.
What to watch next is whether Scherzer can meet the timeline implied by the injured list and make it back quickly, and how Toronto’s rotation responds in his absence. If his return is delayed, it could lengthen the period in which the Blue Jays must distribute starts and innings among other arms. If he comes back on schedule, it will still leave the organization with an open question about durability for the rest of the season. Either way, the next decisions from the team’s medical and pitching staffs will carry outsized importance for Toronto’s month-to-month momentum.